With the development of molecular and proteomics in gastric cancer, many proteins have been the potential markers for early diagnosis, prognosis and therapeutic targets of gastric carcinoma, among them c-Met [9], PKP2 and PKP3 [10], Ezrin [33], are the known ones.Moreover, other molecular biomarkers are currently in study. The gene discussed is PKP2; the disease is gastric cancer.